Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2021
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands
Viviane J Tschan, Francesca Borgna, Roger Schibli, et al.
Clinical Oral Investigations
|
September 23, 2000
A retrospective classification of tooth injuries using a new scoring system
A Filippi, J Tschan, Y Pohl, et al.
International Journal of Sports Medicine
|
July 7, 2007
Exercise capacity in athletes with mouthguards
T von Arx, R Flury, J Tschan, et al.
Cancers
|
November 26, 2022
[<sup>225</sup>Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [<sup>225</sup>Ac]Ac-PSMA-617
Sarah D Busslinger, Viviane J Tschan, Olivia K Richard, et al.
Molecules (Basel, Switzerland)
|
June 4, 2020
Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile
Luisa M Deberle, Viviane J Tschan, Francesca Borgna, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1988
Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study
H G Seydel, L Leichman, R Byhardt, et al.
Molecular Pharmaceutics
|
February 24, 2023
Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals
Rahel H Wallimann, Patrick Schindler, Heloïse Hensinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 31, 2022
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer
Viviane J Tschan, Francesca Borgna, Sarah D Busslinger, et al.
Molecular Pharmaceutics
|
May 11, 2022
Preclinical Investigations to Explore the Difference between the Diastereomers [<sup>177</sup>Lu]Lu-SibuDAB and [<sup>177</sup>Lu]Lu-RibuDAB toward Prostate Cancer Therapy
Francesca Borgna, Luisa M Deberle, Sarah D Busslinger, et al.
Journal of Proteome Research
|
June 16, 2025
Quantitative Proteomic Analysis Reveals Different Functional Subtypes among <i>IDH</i>-Wildtype Glioblastoma
Michèle Amer Salem, Jean-Louis Boulay, Marie-Françoise Ritz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2021
Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands
Viviane J Tschan, Francesca Borgna, Roger Schibli, et al.
Clinical Oral Investigations
|
September 23, 2000
A retrospective classification of tooth injuries using a new scoring system
A Filippi, J Tschan, Y Pohl, et al.
International Journal of Sports Medicine
|
July 7, 2007
Exercise capacity in athletes with mouthguards
T von Arx, R Flury, J Tschan, et al.
Cancers
|
November 26, 2022
[<sup>225</sup>Ac]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [<sup>225</sup>Ac]Ac-PSMA-617
Sarah D Busslinger, Viviane J Tschan, Olivia K Richard, et al.
Molecules (Basel, Switzerland)
|
June 4, 2020
Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile
Luisa M Deberle, Viviane J Tschan, Francesca Borgna, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1988
Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG Study
H G Seydel, L Leichman, R Byhardt, et al.
Molecular Pharmaceutics
|
February 24, 2023
Inductively Coupled Plasma Mass Spectrometry─A Valid Method for the Characterization of Metal Conjugates in View of the Development of Radiopharmaceuticals
Rahel H Wallimann, Patrick Schindler, Heloïse Hensinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 31, 2022
Preclinical investigations using [<sup>177</sup>Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer
Viviane J Tschan, Francesca Borgna, Sarah D Busslinger, et al.
Molecular Pharmaceutics
|
May 11, 2022
Preclinical Investigations to Explore the Difference between the Diastereomers [<sup>177</sup>Lu]Lu-SibuDAB and [<sup>177</sup>Lu]Lu-RibuDAB toward Prostate Cancer Therapy
Francesca Borgna, Luisa M Deberle, Sarah D Busslinger, et al.
Journal of Proteome Research
|
June 16, 2025
Quantitative Proteomic Analysis Reveals Different Functional Subtypes among <i>IDH</i>-Wildtype Glioblastoma
Michèle Amer Salem, Jean-Louis Boulay, Marie-Françoise Ritz, et al.
Page
of 2